Core Viewpoint - Kolun Pharmaceutical (002422.SZ) announced that five of its products have been included in the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog (2025) as per the notification from the National Healthcare Security Administration and the Ministry of Human Resources and Social Security [1] Group 1 - The inclusion of five products in the National Basic Medical Insurance Drug Catalog is a significant development for the company [1] - This move is expected to enhance the market access and sales potential of the included products [1] - The announcement reflects the company's alignment with national healthcare policies and its commitment to expanding its product offerings in the healthcare sector [1]